![NEXT SUPER STOCK Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) Psilocybin Autism Phase 2A Clinical Trials Update 12/12/2022 NEXT SUPER STOCK Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) Psilocybin Autism Phase 2A Clinical Trials Update 12/12/2022](https://www.wallstreetreporter.com/wp-content/uploads/2023/02/WSR-Thumb-NOVA-678x381.png)
NEXT SUPER STOCK Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) Psilocybin Autism Phase 2A Clinical Trials Update 12/12/2022
Nova Mentis Life Science Corp. Announces the Launch of Its Us-Based Observational Study Nm- 101 -March 03, 2021 at 06:56 am EST | MarketScreener
![Nova Mentis (CSE:NOVA) signs research contract with KGK Science for Phase II A clinical trial | The Market Herald Canada Nova Mentis (CSE:NOVA) signs research contract with KGK Science for Phase II A clinical trial | The Market Herald Canada](https://themarketherald.ca/wp-content/uploads/2022/06/24211-Nova-Mentis-Life-Science-1280x720-e1676388833113.jpg)